登录查看更多内容

ISO 10993/17 (2023) published

Chorley Consulting Ltd

An independent toxicology consultancy focused on developing the most practical path forward for your medical device

发布日期: 2023年9月13日

The latest update to ISO 10993/17 (Toxicological risk assessment of medical device constituents) has been published today. This should now be considered as state of the art for toxicological risk assessment of your medical device extracts. Contact us if you would like to discuss the impact on your project.

要查看或添加评论，请登录

Chorley Consulting Ltd的更多文章

2024年11月4日

Welcome Vicki!

We are thrilled to announce that Victoria Darbyshire joins us this week as a Safety Assessor. Vicki has extensive…

3 条评论
2024年2月21日

FDA Reminds Medical Device Manufacturers to Scrutinize Third-Party-Generated Data

FDA have issued a warning to device manufacturers regarding the quality of testing data generated by third party labs…
2024年1月9日

Welcome Laura!

We are very excited to let you all know that Laura West joins us this week as an Associate Safety Assessor. Laura has…
2023年7月26日

Understanding Biocompatibility for Medical Devices

I am delivering this classroom and online course for Educo Life Sciences - Understanding Biocompatibility for Medical…
2023年7月20日

Demystifying Chemical Characterisation

Come and join us in Manchester on 4th October 2023. This one day event brings together experts from both Element and…
2023年7月4日

MHRA publish an update on future medical device regulations

MHRA have just (1 July) published an update on future medical device regulations in the UK. Legislation now enables CE…
2023年6月28日

Biocompatibility Insights 2023

We are very happy to be sponsoring and exhibiting at Biocompatibility Insights conference in September. Looking forward…
2023年6月6日

Computational Approaches for the Assessment of E&Ls

Our friend, Ron Brown, will be delivering a short course on computation toxicology in Lund, Sweden on 13 June. It…
2023年5月31日

Only 1 week to go

Just a week to go until Med Tech Innovation Expo. The full Chorley team will be on stand B39.
2023年5月26日

Biocompatibility of Medical Devices – Responsibilities of the Supply Chain

The requirement to demonstrate the biological safety/biocompatibility of medical devices is described in MDR and…

See all articles

社区洞察

Research and Development (R&D)

What are the steps to ensure your R&D lab is licensed and certified?
Contract Negotiation

How can you negotiate contracts in the health care and pharmaceutical industries?
Quality Management

What are the best ways to improve GMP quality while keeping costs low?
GMP

How do you communicate and collaborate with GCP or GMP auditors or inspectors?
Laboratory Management

You're faced with multiple discrepancies in test results. How do you decide which ones to address first?
GMP

How do you talk to a GMP auditor?
GMP

How do you conduct accelerated stability testing to predict shelf life?
GMP

How do you communicate changes to GMP standards?
Call Center Administration

What does a regulatory associate do?
Quality Management

How can you develop problem-solving skills in a GMP environment?

其他会员也浏览了

PHARMA NEWS & TRENDS . abril 2024

Formiventos 11 个月
Planning and Process for Compliant Post-Market Surveillance

IMed Consultancy Ltd 1 年
Draft manufacturer self-declaration and notified body confirmation letter for Regulation (EU) 2024/1860 available

mdi Europa GmbH 6 个月
MDR and IVDR amending regulation published

mdi Europa GmbH 7 个月
FDA Starts Advisory Program Pilot to Reduce ‘Valley of Death’ Risk for Medical Devices

MedThree Insurance Group 2 年
Comparing ISO 13485 and FDA 21 CFR Part 820

CENK KILIC KALKAN 2 年
American Association of Tissue Banks (AATB) 2024 Webinar Series: From Concept to SE Letter

Laura Rose, PhD 4 个月
And a miracle happens!

Dirk Beth 6 年
A Notified Body’s perspective on the requirements for new interactions with Notified Bodies under the MDR with respect to combination products

Marija Capek 4 年
Notification Vs Registration at ANVISA.

Marcelo Brisolla 5 个月

Chorley Consulting Ltd的更多文章

Welcome Vicki!

FDA Reminds Medical Device Manufacturers to Scrutinize Third-Party-Generated Data

Welcome Laura!

Understanding Biocompatibility for Medical Devices

Demystifying Chemical Characterisation

MHRA publish an update on future medical device regulations

Biocompatibility Insights 2023

Computational Approaches for the Assessment of E&Ls

Only 1 week to go

Biocompatibility of Medical Devices – Responsibilities of the Supply Chain

社区洞察

其他会员也浏览了

PHARMA NEWS & TRENDS . abril 2024

Planning and Process for Compliant Post-Market Surveillance

Draft manufacturer self-declaration and notified body confirmation letter for Regulation (EU) 2024/1860 available

MDR and IVDR amending regulation published

FDA Starts Advisory Program Pilot to Reduce ‘Valley of Death’ Risk for Medical Devices

Comparing ISO 13485 and FDA 21 CFR Part 820

American Association of Tissue Banks (AATB) 2024 Webinar Series: From Concept to SE Letter

And a miracle happens!

A Notified Body’s perspective on the requirements for new interactions with Notified Bodies under the MDR with respect to combination products

Notification Vs Registration at ANVISA.